Tokyo Ohka Kogyo
B2B specialty chemicals: recurring consumable sales of photoresists and high-purity chemicals to chipmakers (spec-in, qualification-locked). Now a pure materials company - the legacy process-equipment business was transferred in Q1 2025 (booked as an extraordinary gain).
Earnings, margins, COGS & capex
Second consecutive record year in FY2025 (Dec year-end): net sales 237.0B yen (+17.9%), operating income 47.4B yen (+43.2%, 20.0% margin), net income 33.3B yen (+47.0%), EBITDA 56.2B yen (+35.7%), ROE 15.6%. Note: FY2025 operating income included a ~5.5B yen one-off inventory-recognition gain and net income an extraordinary gain on the equipment-business transfer. Growth is quality-led: EUV resist +50% YoY (per earnings-call coverage), WHS advanced-packaging-related materials +40%, advanced (ArF/EUV) materials +20%. Q1 FY2026 accelerated (sales 67.1B yen +23.6%, OP 15.0B yen +53.8%) and management held FY2026 guidance of 261.0B yen revenue / 52.2B yen OP / net income +5.0% (~35B yen), a third straight record year. TOK2027 mid-term targets were revised up in Feb 2026 to 295B yen revenue / 58B yen OP / 72B yen EBITDA / 14% ROE (from 48B yen OP / 61B yen EBITDA). Balance sheet is fortress-like: 67.9% equity ratio, net cash, total assets 335.3B yen.
Revenue trend
Margins
expanding on EUV/advanced-materials mix shift
up; includes an extraordinary gain on the equipment-business transfer
still rising
up
COGS structure
Dominated by specialty raw materials (polymers, photoacid generators, high-purity solvents), high-purity manufacturing/cleanroom operating costs, and depreciation on capacity expansion; management flagged raw-material price rises from Q2 FY2026 with cost pass-through planned. Mix shift toward EUV resist and advanced packaging materials (far higher price-per-liter than legacy g/i-line resist) is the main margin lever; high-purity chemicals (109.4B yen, 46% of FY2025 sales) is the lower-margin volume business.
Capex
Record 35.8B yen planned for FY2026 (+24.6% vs FY2025's 28.7B yen; ~13.7% of guided sales), part of a 76B yen three-year program: EUV resist capacity (Koriyama, Japan and Incheon, South Korea) plus next-generation EUV resist development including metal-oxide resist (MOR) work and advanced-packaging materials capacity; R&D rising to 18.2B yen in FY2026. Funded from operating cash flow; net cash maintained.
Latest earnings
Strongly ahead of the full-year run-rate (Q1 delivered ~29% of FY OP guidance); management conservatively held guidance
FY2026: revenue 261.0B yen (+10.1%), operating income 52.2B yen (+10.2%; +15.6% excluding FY2025's one-off inventory gain), net income +5.0% (~35B yen), assumed FX 150 JPY/USD; dividend raised to 80 yen (from 72 yen; FY2025 was the 8th consecutive annual increase, ~4.0% DOE policy). TOK2027 mid-term targets revised UP in Feb 2026: 295B yen revenue, 58B yen OP, 72B yen EBITDA, 14% ROE
- EUV resist growth
- +50% FY2025 (earnings-call coverage); advanced (ArF/EUV) materials guided +10% FY2026
- WHS / back-end materials growth
- WHS +40% FY2025 and ~+170% guided FY2026 (earnings-call coverage); back-end process materials segment guided +30% FY2026
- Electronic functional materials segment
- 124.7B yen FY2025 (+16.0%); +29.0% to 35.9B yen in Q1 FY2026; FY2026 guide 140.0B yen (+12.3%)
- High-purity chemicals segment
- 109.4B yen FY2025 (+19.6%); +17.2% to 30.0B yen in Q1 FY2026
- FY2026 dividend
- 80 yen/share planned (72 yen FY2025)
Growth drivers
- Generative-AI semiconductor buildout — EUV resist sales +50% in FY2025 (per FY2025 earnings-call coverage); advanced (ArF/EUV) materials guided +10% in FY2026
- Back-end/advanced-packaging materials tied to HBM/AI accelerators: segment guided +30% in FY2026, with WHS materials specifically projected around +170% (earnings-call coverage); mid-term plan targets WHS +700% and EUV resist +150% FY2024->FY2027
- Advanced (ArF immersion + EUV) resist share gains as the world's #1 photoresist supplier
- High-purity chemicals volume growth with fab capacity additions in Japan, Taiwan, US, Korea (+19.6% FY2025, to 109.4B yen)
- Next-gen resist optionality: in-house metal-oxide resist (MOR) development aimed at high-NA EUV nodes
Bull & bear
TOK is the purest large-cap-quality play on lithography materials intensity: EUV layer growth plus HBM packaging materials compound volume regardless of which chipmaker wins, margins are structurally re-rating as mix shifts to EUV, and the company is net cash with rising dividends and upgraded mid-term targets.
- Consumables economics: resists are burned every wafer pass - revenue scales with wafer starts x layer count, and EUV layers per device keep rising; EUV resist grew ~50% in FY2025 and the mid-term plan targets +150% FY2024->FY2027
- Second engine firing: WHS advanced-packaging materials guided ~+170% in FY2026 (and +700% FY2024->FY2027) on HBM/AI-accelerator demand - a new S-curve largely absent from the stock two years ago
- Operating margin went 16.5% -> 20.0% -> 22.4% (Q1 FY2026) on mix; TOK2027 targets were already raised once (OP 48B -> 58B yen), and Q1 delivered ~29% of full-year OP guidance, implying beats ahead
- Qualification moat means share is sticky for years once designed into a node; with JSR taken private and inward-focused, TOK is the natural share gainer at leading-edge customers
- Shareholder returns improving: FY2025 was the 8th straight dividend increase (63 -> 72 yen), 80 yen planned for FY2026, 4.0% DOE policy, net cash funding record capex without leverage strain
- Not dependent on one customer: sells to TSMC, Samsung, Intel, Micron, SK Hynix, Kioxia - a neutral arms dealer across the AI supply chain
A cyclical specialty-chemicals company priced like a secular compounder: ~41x trailing earnings after a ~174% one-year run, with growth concentrated in an AI capex cycle, an unresolved resist-technology transition at high-NA EUV, and PFAS/China-policy overhangs.
- Valuation: ~1.36T yen market cap on 33.3B yen FY2025 net income is ~41x trailing and ~39x guided FY2026 (~35B yen NI) - well above the mid-cycle multiples Japanese semi-materials names historically commanded, for a company guiding +10% revenue growth
- Cycle risk is real, not theoretical: FY2023 revenue fell in the memory downturn; if AI infrastructure capex digests, EUV resist and WHS growth rates would compress abruptly from +50%/+170% comparisons
- Technology succession risk: high-NA EUV may favor metal-oxide resists (Inpria/JSR) or Lam's dry resist over TOK's chemically amplified franchise; TOK's own MOR effort is still in development, not yet a proven win
- Earnings quality: FY2025 OP included a ~5.5B yen one-off inventory-recognition gain and net income an extraordinary gain on the equipment-business transfer - underlying growth is strong but slightly below headline (guidance itself is +15.6% OP ex one-offs)
- FX cuts both ways: guidance assumes 150 JPY/USD vs ~162 spot, so today's rate helps - but a yen rally would hit reported results, and raw-material inflation is flagged from Q2 FY2026
- China policy squeeze from both sides: Japanese export controls limit advanced-material sales into China while subsidized Chinese resist entrants erode the legacy (g/i-line, KrF) tail
- Nearly half the business (high-purity chemicals, 109.4B yen) is lower-margin and does not deserve the multiple the market is paying for the EUV story
What it is worth
Earnings multiple on FY2026 guided net income (company guide: +5.0%, ~35B yen; Q1 run-rate suggests upside toward 38-40B yen), cross-checked vs TOK2027 targets (58B yen OP, 72B yen EBITDA, 14% ROE) and the lower mid-cycle multiples Japanese semi-materials names carried before the AI re-rating
~$4.5-5.5B (0.75-0.9T yen)
AI capex digestion in 2027 plus high-NA resist share loss to metal-oxide/dry alternatives compresses growth to single digits - 25-30x on ~30B yen NI, reverting toward historical materials multiples
~$8-8.5B (1.3-1.4T yen)
guidance-line execution (52.2B yen OP, ~35B yen NI) at ~38-40x - roughly the current price, i.e. the market already pays for the guide
~$10-11B (1.6-1.8T yen)
FY2026 beats (Q1 pace of ~29% of FY OP guide implies upside), TOK2027 targets hit early, WHS momentum sustains - ~40-45x on ~40B yen net income as the scarcity premium for the listed pure-play resist leader holds
At ~1.36T yen (~$8.4B) market cap, TOK trades ~41x FY2025 EPS and ~39x guided FY2026; EV is ~4-5% lower on net cash (69.2B yen cash vs ~20B yen debt). The multiple prices continued AI-cycle strength and a successful metal-oxide resist transition. Not financial advice.
SWOT
Strengths
- World #1 photoresist market share (widely cited at roughly a quarter of the global market) across g-line/i-line/KrF/ArF/EUV - the broadest resist portfolio in the industry
- Qualification lock-in — resists are spec'd into customer process recipes for the life of a node; switching costs are extreme
- Deep co-development relationships with TSMC, Samsung, Intel, Micron, SK Hynix and local production near customers (Japan, US, Taiwan, Korea, China)
- Fortress balance sheet — net cash (69.2B yen cash vs ~20B yen debt), 67.9% equity ratio, self-funded record capex
- Margin structure improving structurally as EUV/advanced mix rises (OP margin 16.5% -> 20.0% -> 22.4%)
Weaknesses
- Scale: ~$1.5B revenue specialty player; R&D and capex budgets are small vs diversified giants (Shin-Etsu, Fujifilm, Merck KGaA electronics)
- High-purity chemicals is ~46% of sales at structurally lower margin and more cyclical/commodity-like
- Semiconductor-cycle beta: FY2023 showed revenue can decline in a memory downturn
- Customer concentration in a handful of leading-edge chipmakers; pricing power constrained by powerful buyers
- FX sensitivity — yen cost base with global sales - FY2026 guidance assumes 150 JPY/USD, so spot ~162 is a cushion, but a yen rally is a direct headwind to reported results
Opportunities
- EUV layer counts rising every node (logic 2nm/1.4nm, DRAM 1-gamma) multiplies resist consumption per wafer; TOK2027 targets EUV resist +150% FY2024->FY2027
- HBM and 2.5D/3D advanced packaging materials (WHS targeted +700% FY2024->FY2027) - a second growth engine beyond lithography
- Metal-oxide resist (MOR) development for high-NA EUV — TOK investing to contest the next resist paradigm rather than cede it
- Fab construction wave (US CHIPS fabs, Japan Rapidus/TSMC Kumamoto, Korea) expands the high-purity chemicals TAM close to TOK's plants
- JSR's take-private by JIC creates customer appetite for a stable, independent #1 supplier
Threats
- Resist paradigm shift risk — Lam Research's dry (deposition-based) resist and Inpria/JSR metal-oxide resists could displace chemically amplified resists at high-NA EUV
- AI capex cycle turning — current growth is concentrated in generative-AI demand; an AI digestion phase would hit EUV/WHS growth rates hard
- PFAS regulation — photoresists and ancillaries historically rely on fluorinated chemistries; reformulation cost and regulatory restrictions are a live industry risk
- Geopolitics: Japan export controls on advanced chip materials to China, and Chinese domestic resist localization efforts, could shrink the China revenue pool (analysis context only)
- Valuation/momentum reversal — stock ~+174% in a year to ~41x trailing earnings leaves little room for execution slips
Moats, dependencies & bottlenecks
Moats
Node-lifetime (5-10+ yrs per design win) Resists are validated into a customer's process recipe; requalifying a competitor risks yield - customers almost never switch mid-node
Durable while chemically amplified resists dominate Widely cited at roughly a quarter of the global photoresist market; only supplier strong across all wavelengths g-line through EUV
Decades of tacit formulation knowledge and on-site engineers embedded with TSMC/Samsung/Intel; not reverse-engineerable from patents
Moderate-strong Meeting particle/metal-ion contamination specs at scale is a multi-year capability barrier for new entrants (notably Chinese entrants)
Plants near customers in Japan, US, Taiwan, Korea, China lower logistics/qualification friction versus distant challengers
Dependencies
EUV resist growth is downstream of EUV layer adoption; a slower high-NA ramp defers TOK's richest mix
Customer concentration A handful of buyers set volumes and exert pricing power; neutral-supplier position mitigates single-customer risk
FY2025-26 growth is explicitly AI-led (EUV +50%, WHS ~+170% guide); cycle digestion is the main earnings risk
polymers, high-purity solvents) Narrow supplier base for PAGs and resist polymers (largely Japanese specialty chemical makers); company flags raw-material price rises from Q2 FY2026
Guidance assumes 150 JPY/USD; spot ~162 (Jul 2026) is a cushion, but a yen rally is a direct headwind
Regulatory/geopolitical Tokyo's alignment with US controls constrains advanced-material sales to Chinese fabs; TOK also operates a China plant (analysis context only)
Advantages
- Pure consumables revenue model since the Q1 2025 equipment-business transfer - recurring, wafer-volume-linked, no equipment lumpy-order risk
- Vendor-neutral exposure to every leading-edge roadmap (logic, DRAM, NAND, packaging) - wins whichever chipmaker wins AI
- Structurally rising materials intensity per wafer (more EUV layers, more packaging steps) gives growth above wafer-start growth
- Net-cash balance sheet lets TOK outspend the downturn on R&D/capacity while levered peers cut
- Japanese materials ecosystem advantage — co-located with Tokyo Electron (coat/develop tracks), suppliers, and Rapidus/imec programs
Weaknesses
- Sub-scale revenue base (~$1.5B) versus the multi-billion-dollar electronics-materials arms of Shin-Etsu, Fujifilm, Merck KGaA
- ~46% of sales in lower-margin high-purity chemicals dilutes the advanced-materials story
- FY2025 headline profits included one-off items (inventory-recognition gain in OP; equipment-transfer gain in net income) - underlying margins slightly below headline
- R&D bet concentration — if chemically amplified resists lose high-NA EUV, TOK must win with its in-development MOR from behind Inpria's head start
- Limited pricing power against top-5 semiconductor buyers despite #1 share
Bottlenecks
- EUV resist capacity — record 35.8B yen FY2026 capex (Koriyama and Incheon expansions) is aimed at debottlenecking; qualification of new lines takes quarters
- Customer qualification cycles (6-18 months) cap how fast new products (MOR, packaging materials) convert to revenue
- PFAS-compliant reformulation bandwidth across the portfolio
- Engineering talent for resist formulation - a scarce, mostly Japan-based skill pool
- High-purity logistics — chemicals must ship contamination-free, favoring local plants and limiting how fast footprint can flex
Top signals & trends
Top signals
Q1 = ~29% of FY OP guide; classic conservative Japanese guide, sets up beats/raises
Management raising the bar mid-plan is rare and signals order-book visibility
HBM/AI-accelerator packaging is becoming a second growth engine
Capital-return discipline improving alongside record capex
Momentum crowding; multiple assumes the AI materials cycle persists uninterrupted
Confidence signal, but raises depreciation and downside operating leverage if demand turns
Cushion versus guidance at current rates; embeds FX-reversal risk
Trends
Strongly positive · Direct driver of EUV resist +50% FY2025 and the WHS ~+170% FY2026 guide
Positive with a technology-transition risk tail · More layers = more resist; but high-NA may shift chemistry toward metal-oxide/dry resist
Expands TOK's packaging materials TAM beyond front-end lithography
Industry-wide reformulation burden for fluorinated resist chemistries
New fabs near TOK plants lift high-purity chemicals volumes
Negative at the margin · Legacy-resist share erosion in China; advanced sales constrained by policy (analysis context only)
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Key Japanese supplier of photoacid generators (PAGs), a critical resist input
Specialty polymers/solvents and semiconductor process chemicals
Japanese specialty polymer/solvent makers (Maruzen Petrochemical, Osaka Organic Chemical TSE:4187) Narrow-base suppliers of resist polymers and monomers
Largest EUV user globally; TOK operates in Taiwan close to fabs
Foundry + memory (HBM) customer; TOK has Korean production (TOKAM, Incheon)
18A/14A EUV and high-NA early adopter
DRAM/HBM customer; EUV insertion in 1-gamma DRAM
HBM leader - key driver of packaging materials demand
NAND customer (legacy + advanced resist volumes)
Closest EUV/ArF resist rival; owns Inpria, the metal-oxide resist leader - the main high-NA threat
Top-3 resist player (strong KrF/ArF/EUV) with vastly larger balance sheet
Electronic materials arm competes in ArF/EUV resists and CMP/packaging materials
Advanced resist competitor at leading-edge nodes
Dry (deposition/etch-based) photoresist for EUV - a substitute technology, not a chemical peer
Broad electronic materials incl. ancillaries and specialty chemicals
Electronics segment competes in packaging/lithography ancillary materials
Korean resist maker gaining share at Samsung, incl. localized EUV effort
Competes in high-purity process chemicals/handling adjacencies rather than resists